Lene Jensen

1.0k total citations
11 papers, 846 citations indexed

About

Lene Jensen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lene Jensen has authored 11 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Lene Jensen's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lene Jensen is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lene Jensen collaborates with scholars based in Denmark, United Kingdom and Austria. Lene Jensen's co-authors include Paul Rolan, Milan Zdravković, Henrik Agersø, Anne Flint, Christoph Kapitza, Leszek Nosek, Helle Bøggild Hartvig, Christine B. Jensen, Mette Lund Pedersen and Palle J. Pedersen and has published in prestigious journals such as Diabetologia, Annals of the Rheumatic Diseases and Clinical Pharmacokinetics.

In The Last Decade

Lene Jensen

11 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lene Jensen Denmark	9	722	459	330	156	71	11	846
Grethe Jakobsen Denmark	7	1.2k 1.7×	607 1.3×	745 2.3×	207 1.3×	117 1.6×	10	1.4k
Mario Widel United States	7	764 1.1×	430 0.9×	281 0.9×	139 0.9×	26 0.4×	11	922
Christopher Sorli United States	13	832 1.2×	421 0.9×	443 1.3×	286 1.8×	25 0.4×	28	1.2k
Jorma Strand Denmark	4	759 1.1×	456 1.0×	281 0.9×	196 1.3×	14 0.2×	5	836
Bernice Ellis United States	7	313 0.4×	233 0.5×	158 0.5×	82 0.5×	45 0.6×	10	434
Deborah T. Cirkel United Kingdom	8	463 0.6×	221 0.5×	157 0.5×	110 0.7×	19 0.3×	8	529
Xiaosu Ma United States	10	451 0.6×	169 0.4×	227 0.7×	219 1.4×	47 0.7×	22	670
Silvia Ciani Italy	5	295 0.4×	197 0.4×	138 0.4×	60 0.4×	56 0.8×	5	411
Iresha Welungoda Australia	6	339 0.5×	206 0.4×	99 0.3×	89 0.6×	43 0.6×	7	475
M. Dodson Michael United States	13	285 0.4×	212 0.5×	293 0.9×	28 0.2×	33 0.5×	19	592

Countries citing papers authored by Lene Jensen

Since Specialization

Citations

This map shows the geographic impact of Lene Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lene Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lene Jensen more than expected).

Fields of papers citing papers by Lene Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lene Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lene Jensen. The network helps show where Lene Jensen may publish in the future.

Co-authorship network of co-authors of Lene Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Lene Jensen. A scholar is included among the top collaborators of Lene Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lene Jensen. Lene Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Korsatko, Stefan, Lene Jensen, Martina Brunner, et al.. (2018). Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial. Diabetes Obesity and Metabolism. 20(11). 2565–2573. 20 indexed citations

Ikushima, Ippei, Lene Jensen, Anne Flint, et al.. (2018). A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects. Advances in Therapy. 35(4). 531–544. 23 indexed citations

Jensen, Lene, Viera Kupčová, Gerhard Arold, Jonas Pettersson, & Julie Hjerpsted. (2017). Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment. Diabetes Obesity and Metabolism. 20(4). 998–1005. 48 indexed citations

Jensen, Lene, Hans Helleberg, Ad F. Roffel, et al.. (2017). Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species. European Journal of Pharmaceutical Sciences. 104. 31–41. 124 indexed citations

Mader, Julia K., Lene Jensen, Steen H. Ingwersen, et al.. (2016). Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus. Clinical Pharmacokinetics. 55(11). 1457–1463. 11 indexed citations

Pieber, Thomas R., Stefan Korsatko, Lene Jensen, et al.. (2015). Counter‐regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo‐controlled, double‐blind, crossover trial. Diabetes Obesity and Metabolism. 17(8). 742–750. 36 indexed citations

Kapitza, Christoph, Leszek Nosek, Lene Jensen, et al.. (2014). Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. The Journal of Clinical Pharmacology. 55(5). 497–504. 125 indexed citations

Jensen, Lene, et al.. (2012). FRI0196 NNC0109-0012 (anti-IL-20 MAB), well tolerated in healthy subjects and patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. 379–379. 4 indexed citations

Rasmussen, Michael Højby, Lene Jensen, Thomas W. Anderson, Thomas Klitgaard, & Jesper Madsen. (2010). Multiple doses of pegylated long‐acting growth hormone are well tolerated in healthy male volunteers and possess a potential once‐weekly treatment profile. Clinical Endocrinology. 73(6). 769–776. 14 indexed citations

10.

Agersø, Henrik, et al.. (2002). The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia. 45(2). 195–202. 438 indexed citations

11.

Wilken, Michael, et al.. (2000). An immunoassay for the GLP-1 derivative NN2211. 1. 148. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact